These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 4111287)

  • 21. [Secondary hyperaldosteronism].
    Veyrat R; Muller AF; Mach RS
    Schweiz Med Wochenschr; 1968 Jan; 98(3):65-75. PubMed ID: 4299459
    [No Abstract]   [Full Text] [Related]  

  • 22. Selective hypoaldosteronism with hyperkalemia.
    Perez G; Siegel L; Schreiner GE
    Ann Intern Med; 1972 May; 76(5):757-63. PubMed ID: 4337136
    [No Abstract]   [Full Text] [Related]  

  • 23. Plasma renin activity and aldosterone secretion in congenital adrenal hyperplasia.
    Godard C; Riondel AM; Veyrat R; Mégevand A; Muller AF
    Pediatrics; 1968 May; 41(5):883-904. PubMed ID: 5654836
    [No Abstract]   [Full Text] [Related]  

  • 24. Additive effects of a sodium chloride restricted diet and furosemide administration in healthy dogs.
    Lovern CS; Swecker WS; Lee JC; Moon ML
    Am J Vet Res; 2001 Nov; 62(11):1793-6. PubMed ID: 11703026
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Medium term effects of different dosage of diuretic, sodium, and fluid administration on neurohormonal and clinical outcome in patients with recently compensated heart failure.
    Paterna S; Parrinello G; Cannizzaro S; Fasullo S; Torres D; Sarullo FM; Di Pasquale P
    Am J Cardiol; 2009 Jan; 103(1):93-102. PubMed ID: 19101237
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of acute and chronic administration of propranolol on blood pressure and plasma renin activity in hypertensive patients.
    Stokes GS; Weber MA; Thornell IR; Stoker LM
    Prog Biochem Pharmacol; 1974; 9():29-44. PubMed ID: 4612559
    [No Abstract]   [Full Text] [Related]  

  • 27. [Pathogenesis of essential hypertension with suppressed plasma renin activity].
    Uchida K
    Nihon Naibunpi Gakkai Zasshi; 1972 Dec; 48(9):674-84. PubMed ID: 4675750
    [No Abstract]   [Full Text] [Related]  

  • 28. Furosemide chronopharmacology.
    Meyer BH; Müller FO; Gray IP; Grigoleit HG
    S Afr Med J; 1982 Dec; 62(26):975-8. PubMed ID: 6755768
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The influence of dietary potassium on the renin and aldosterone response to diuretic-induced volume depletion.
    Dluhy RG; Cain JP; Williams GH
    J Lab Clin Med; 1974 Feb; 83(2):249-55. PubMed ID: 4359406
    [No Abstract]   [Full Text] [Related]  

  • 30. Plasma renin activity and aldosterone excretion after renal homotransplantation.
    Greene JA; Vander AJ; Kowalczyk RS
    J Lab Clin Med; 1968 Apr; 71(4):586-95. PubMed ID: 4870609
    [No Abstract]   [Full Text] [Related]  

  • 31. Urocortin 2 inhibits furosemide-induced activation of renin and enhances renal function and diuretic responsiveness in experimental heart failure.
    Rademaker MT; Charles CJ; Nicholls MG; Richards AM
    Circ Heart Fail; 2009 Nov; 2(6):532-40. PubMed ID: 19919977
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Renin, angiotensin, corticosteroids, and electrolyte balance in Addison's disease.
    Brown JJ; Fraser R; Lever AF; Robertson JI; James VH; McCusker J; Wynn V
    Q J Med; 1968 Jan; 37(145):97-118. PubMed ID: 4297956
    [No Abstract]   [Full Text] [Related]  

  • 33. System dynamics modeling of renin aldosterone and electrolyte changes induced by furosemide in hypertensive patients.
    Hsieh BS; Kuo YM; Hsieh CH; Lee PW
    Taiwan Yi Xue Hui Za Zhi; 1987 Jan; 86(1):17-26. PubMed ID: 3553421
    [No Abstract]   [Full Text] [Related]  

  • 34. [The renin-angiotensin system in chronic idiopathic pituitary insufficiency].
    Levin GM; Moyano MB; Bergadá C
    Medicina (B Aires); 1978; 38(5):519-23. PubMed ID: 216876
    [No Abstract]   [Full Text] [Related]  

  • 35. Changes in urinary aldosterone excretion and plasma renin activity in response to dietary sodium chloride deprivation in man [proceedings].
    Gordon D; James VH; Peart WS; Wilson GA
    J Physiol; 1978 Jul; 280():43P-44P. PubMed ID: 690899
    [No Abstract]   [Full Text] [Related]  

  • 36. [Various aspects of the regulation of aldosterone secretion].
    Jungmann E; Ackerman A; Panijel-Rath C; Schöffling K
    Med Klin Prax; 1982 Apr; 77(8):58-63. PubMed ID: 6281634
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Plasma renin activity in patients with essential hypertension].
    Feltynowski T
    Kardiol Pol; 1977; 20(1):23-34. PubMed ID: 846053
    [No Abstract]   [Full Text] [Related]  

  • 38. [Determination of plasma renin activity in edematous cirrhosis. Influence of various depletive treatments].
    Cottin S; Miniconi P; Belet JL; Cadudal JL; Talmant JC; Bailleux A
    Sem Hop; 1973 Apr; 49(19):1357-63. PubMed ID: 4355382
    [No Abstract]   [Full Text] [Related]  

  • 39. Non-tumorous "primary" aldosteronism. I. Type relieved by glucocorticoid (glucocorticoid-remediable aldosteronism).
    Salti IS; Stiefel M; Ruse JL; Laidlaw JC
    Can Med Assoc J; 1969 Jul; 101(1):1-10. PubMed ID: 5793351
    [No Abstract]   [Full Text] [Related]  

  • 40. Acute changes in plasma volume, renin activity, and free aldosterone levels in healthy subjects following Fursemide administration.
    Rosenthal J; Boucher R; Nowaczynski W; Genest J
    Can J Physiol Pharmacol; 1968 Jan; 46(1):85-91. PubMed ID: 5642446
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.